United States · FDA National Drug Code directory
STEGLUJAN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0006-5367_2411ef00-2924-45da-9f6c-5dabf1afea1c
- Product NDC
- 0006-5367
- Form
- TABLET, FILM COATED
- Composition / generic term
- ertugliflozin and sitagliptin
- Labeler
- Merck Sharp & Dohme LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20171219
- Source listing expiry
- 20271231
Source-listed ingredients
- ERTUGLIFLOZIN PIDOLATE — 5 mg/1
- SITAGLIPTIN PHOSPHATE — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 BOTTLE (0006-5367-03) · 0006-5367-03
- 90 TABLET, FILM COATED in 1 BOTTLE (0006-5367-06) · 0006-5367-06
- 500 TABLET, FILM COATED in 1 BOTTLE (0006-5367-07) · 0006-5367-07
- 2 BOTTLE in 1 CARTON (0006-5367-09) / 7 TABLET, FILM COATED in 1 BOTTLE (0006-5367-08) · 0006-5367-09
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →